focus -WSS

focus

author：comprehensive 2025-10-01 00:07:13 - browse：717

A person walks past the Palantir sign. -- health tech coverage from STAT — FABRICE COFFRINI/AFP via Getty Images

PALO ALTO, Calif. — At a bustling artificial intelligence conference in June hosted by data heavyweight Palantir, a handful of relative newcomers — hospital executives — milled among government and defense industry customers spiritedly trading new uses for the company’s automation and analytics services.

Palantir is best known for its work in government and intelligence, but early adopters of the company’s nascent health offerings, including leaders from Cleveland Clinic, Tampa General Hospital, and HCA, offered demos and gave keynotes last month explaining applications like sepsis monitoring or staff scheduling tools.

For the hospital systems, it’s an expensive bid to tailor the company’s AI technology to hospital operations — and an attempt to blunt the effects of severe staffing shortages and limited bed space amid a resurgence of in-person care.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： What does generative AI mean for health care? We asked experts
Next article： Melinda French Gates resigns from Gates Foundation

focus

WSS

MassMutual is introducing free genetic testing for members

MassMutual is introducing free genetic testing for members

Why rehabilitation engineers need to center patients in their research

Ethical issues complicate the benefits of medical crowdfunding

What American doctors can learn from their Israeli counterparts

The (many) problems with a new study criticizing cancer screening

Wikipedia

focus

entertainment

Affirmative action in medical school literally saved lives

Biotech execs pursue obesity drug boom: ‘It’s the early innings’

Psychedelics group wrestles with new pharma identity

How to fix cancer clinical trials' diversity problem

As demand for Covid shots wanes, Moderna seeks its next success

BIO: Crackdown on China pharma industry would threaten U.S. drug supply

Medicare proposal to cover medical devices draws a mixed reaction

Exact Sciences stock tumbles despite strong cancer detection sales

The high cost of giving birth even with insurance

FTC falls short on scrutinizing hospital mergers, study says

Wikipedia

Cell therapy fails to slow type 1 diabetes, but safety is established

Bird flu in milk supply is likely coming from asymptomatic cows

Cancer researcher Catriona Jamieson is sending tumors into space

Advances in CAR

Dogs on Prozac: What pet anti

Melinda French Gates resigns from Gates Foundation

focus

focus

focus

hotspot